{"id":14470,"date":"2022-06-15T17:32:00","date_gmt":"2022-06-15T21:32:00","guid":{"rendered":"https:\/\/imedcprod.wpengine.com\/actualites\/toutes-les-nouvelles\/"},"modified":"2022-07-06T11:23:16","modified_gmt":"2022-07-06T15:23:16","slug":"innovative-medicines-canada-regulatory-changes-patient-access-new-medicines","status":"publish","type":"news","link":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/innovative-medicines-canada-regulatory-changes-patient-access-new-medicines\/","title":{"rendered":"Les changements r\u00e9glementaires pourraient avoir un impact sur l\u2019acc\u00e8s des patients aux nouveaux m\u00e9dicaments"},"content":{"rendered":"\n<p><strong>Ottawa, June 15, 2022<\/strong>\u00a0\u2013 Innovative Medicines Canada (IMC), the association representing Canada\u2019s research-based pharmaceutical sector, acknowledges the release of the Parliamentary Budget Officer\u2019s (PBO) report on the long-term impacts of the proposed new basket of comparator countries used by the Patented Medicine Prices Review Board (PMPRB).<\/p>\n\n<p>The report, titled Canadian Patented Drug Prices: Gauging the Change in Reference Countries, highlights that the pending basket changes would have an estimated impact of $2.8 billion per year, and could ultimately reduce Canada\u2019s attractiveness as a destination for pharmaceutical innovation and limit patient access to new medicines.<\/p>\n\n<p>While IMC and its members were encouraged by the significant changes made to the PMPRB regulations due to recent judicial decisions, we remain concerned regarding the long-term impact of the new comparator nations.<\/p>\n\n<p>\u201cWhile we support health-care sustainability, major regulatory changes must strike the right balance between access, cost, and Canada\u2019s competitiveness on a global scale,\u201d said Pamela Fralick, President of Innovative Medicines Canada.<\/p>\n\n<p>Industry recognizes the positive steps taken to date with regard to PMPRB reforms and looks forward to continued collaboration and progress toward ensuring Canadians have access to the latest medicines available globally.<\/p>\n\n<p><strong>About Innovative Medicines Canada<\/strong><\/p>\n\n<p>Innovative Medicines Canada is the national association representing the voice of Canada\u2019s innovative pharmaceutical industry. The association advocates for policies that enable the discovery, development, and delivery of innovative medicines and vaccines to improve the lives of all Canadians and supports the members\u2019 commitment to being a valued partner in the Canadian healthcare system. The association represents 49 companies who invest nearly $1.4 billion in R&amp;D annually, fueling Canada\u2019s knowledge-based economy, while contributing $8 billion to Canada\u2019s economy. Guided by the Code of Ethical Practices, all members work with governments, private payers, healthcare professionals, and stakeholders in a highly ethical manner.<\/p>\n\n<p>For further information:<\/p>\n\n<p>Marise Varanda<br \/>Director, Media Relations &amp; Content<br \/>Telephone: 613-462-5367<br \/>E-mail:\u00a0<a href=\"mailto:media@imc-mnc.ca\">media@imc-mnc.ca<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Ottawa, June 15, 2022\u00a0\u2013 Innovative Medicines Canada (IMC), the association representing Canada\u2019s research-based pharmaceutical sector, acknowledges the release of the [&hellip;]<\/p>\n","protected":false},"featured_media":13985,"template":"","topic":[238],"team-member-id":[],"news-category":[176],"news-tag":[],"class_list":["post-14470","news","type-news","status-publish","has-post-thumbnail","hentry","topic-acces-aux-medicaments","news-category-communique"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Les changements r\u00e9glementaires pourraient avoir un impact sur l\u2019acc\u00e8s des patients aux nouveaux m\u00e9dicaments - Innovative Medicines Canada<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/innovative-medicines-canada-regulatory-changes-patient-access-new-medicines\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Les changements r\u00e9glementaires pourraient avoir un impact sur l\u2019acc\u00e8s des patients aux nouveaux m\u00e9dicaments - Innovative Medicines Canada\" \/>\n<meta property=\"og:description\" content=\"Ottawa, June 15, 2022\u00a0\u2013 Innovative Medicines Canada (IMC), the association representing Canada\u2019s research-based pharmaceutical sector, acknowledges the release of the [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/innovative-medicines-canada-regulatory-changes-patient-access-new-medicines\/\" \/>\n<meta property=\"og:site_name\" content=\"Innovative Medicines Canada\" \/>\n<meta property=\"article:modified_time\" content=\"2022-07-06T15:23:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/innovativemedicines.ca\/wp-content\/uploads\/2022\/06\/browse-by-pmprb-hero.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1280\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/actualites\\\/toutes-les-nouvelles\\\/innovative-medicines-canada-regulatory-changes-patient-access-new-medicines\\\/\",\"url\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/actualites\\\/toutes-les-nouvelles\\\/innovative-medicines-canada-regulatory-changes-patient-access-new-medicines\\\/\",\"name\":\"Les changements r\u00e9glementaires pourraient avoir un impact sur l\u2019acc\u00e8s des patients aux nouveaux m\u00e9dicaments - Innovative Medicines Canada\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/actualites\\\/toutes-les-nouvelles\\\/innovative-medicines-canada-regulatory-changes-patient-access-new-medicines\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/actualites\\\/toutes-les-nouvelles\\\/innovative-medicines-canada-regulatory-changes-patient-access-new-medicines\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/innovativemedicines.ca\\\/wp-content\\\/uploads\\\/2022\\\/06\\\/browse-by-pmprb-hero.jpg\",\"datePublished\":\"2022-06-15T21:32:00+00:00\",\"dateModified\":\"2022-07-06T15:23:16+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/actualites\\\/toutes-les-nouvelles\\\/innovative-medicines-canada-regulatory-changes-patient-access-new-medicines\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/actualites\\\/toutes-les-nouvelles\\\/innovative-medicines-canada-regulatory-changes-patient-access-new-medicines\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/actualites\\\/toutes-les-nouvelles\\\/innovative-medicines-canada-regulatory-changes-patient-access-new-medicines\\\/#primaryimage\",\"url\":\"https:\\\/\\\/innovativemedicines.ca\\\/wp-content\\\/uploads\\\/2022\\\/06\\\/browse-by-pmprb-hero.jpg\",\"contentUrl\":\"https:\\\/\\\/innovativemedicines.ca\\\/wp-content\\\/uploads\\\/2022\\\/06\\\/browse-by-pmprb-hero.jpg\",\"width\":1920,\"height\":1280},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/actualites\\\/toutes-les-nouvelles\\\/innovative-medicines-canada-regulatory-changes-patient-access-new-medicines\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Newsroom\",\"item\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/newsroom\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Newsroom\",\"item\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/newsroom\\\/all-news\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Les changements r\u00e9glementaires pourraient avoir un impact sur l\u2019acc\u00e8s des patients aux nouveaux m\u00e9dicaments\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/\",\"name\":\"Innovative Medicines Canada\",\"description\":\"Transforming Canadians\u2019 lives\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/innovativemedicines.ca\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Les changements r\u00e9glementaires pourraient avoir un impact sur l\u2019acc\u00e8s des patients aux nouveaux m\u00e9dicaments - Innovative Medicines Canada","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/innovative-medicines-canada-regulatory-changes-patient-access-new-medicines\/","og_locale":"fr_FR","og_type":"article","og_title":"Les changements r\u00e9glementaires pourraient avoir un impact sur l\u2019acc\u00e8s des patients aux nouveaux m\u00e9dicaments - Innovative Medicines Canada","og_description":"Ottawa, June 15, 2022\u00a0\u2013 Innovative Medicines Canada (IMC), the association representing Canada\u2019s research-based pharmaceutical sector, acknowledges the release of the [&hellip;]","og_url":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/innovative-medicines-canada-regulatory-changes-patient-access-new-medicines\/","og_site_name":"Innovative Medicines Canada","article_modified_time":"2022-07-06T15:23:16+00:00","og_image":[{"width":1920,"height":1280,"url":"https:\/\/innovativemedicines.ca\/wp-content\/uploads\/2022\/06\/browse-by-pmprb-hero.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/innovative-medicines-canada-regulatory-changes-patient-access-new-medicines\/","url":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/innovative-medicines-canada-regulatory-changes-patient-access-new-medicines\/","name":"Les changements r\u00e9glementaires pourraient avoir un impact sur l\u2019acc\u00e8s des patients aux nouveaux m\u00e9dicaments - Innovative Medicines Canada","isPartOf":{"@id":"https:\/\/innovativemedicines.ca\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/innovative-medicines-canada-regulatory-changes-patient-access-new-medicines\/#primaryimage"},"image":{"@id":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/innovative-medicines-canada-regulatory-changes-patient-access-new-medicines\/#primaryimage"},"thumbnailUrl":"https:\/\/innovativemedicines.ca\/wp-content\/uploads\/2022\/06\/browse-by-pmprb-hero.jpg","datePublished":"2022-06-15T21:32:00+00:00","dateModified":"2022-07-06T15:23:16+00:00","breadcrumb":{"@id":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/innovative-medicines-canada-regulatory-changes-patient-access-new-medicines\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/innovative-medicines-canada-regulatory-changes-patient-access-new-medicines\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/innovative-medicines-canada-regulatory-changes-patient-access-new-medicines\/#primaryimage","url":"https:\/\/innovativemedicines.ca\/wp-content\/uploads\/2022\/06\/browse-by-pmprb-hero.jpg","contentUrl":"https:\/\/innovativemedicines.ca\/wp-content\/uploads\/2022\/06\/browse-by-pmprb-hero.jpg","width":1920,"height":1280},{"@type":"BreadcrumbList","@id":"https:\/\/innovativemedicines.ca\/fr\/actualites\/toutes-les-nouvelles\/innovative-medicines-canada-regulatory-changes-patient-access-new-medicines\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/innovativemedicines.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Newsroom","item":"https:\/\/innovativemedicines.ca\/fr\/newsroom\/"},{"@type":"ListItem","position":3,"name":"Newsroom","item":"https:\/\/innovativemedicines.ca\/fr\/newsroom\/all-news\/"},{"@type":"ListItem","position":4,"name":"Les changements r\u00e9glementaires pourraient avoir un impact sur l\u2019acc\u00e8s des patients aux nouveaux m\u00e9dicaments"}]},{"@type":"WebSite","@id":"https:\/\/innovativemedicines.ca\/fr\/#website","url":"https:\/\/innovativemedicines.ca\/fr\/","name":"Innovative Medicines Canada","description":"Transforming Canadians\u2019 lives","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/innovativemedicines.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"}]}},"_links":{"self":[{"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/news\/14470","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/types\/news"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/media\/13985"}],"wp:attachment":[{"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/media?parent=14470"}],"wp:term":[{"taxonomy":"topic","embeddable":true,"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/topic?post=14470"},{"taxonomy":"team-member-id","embeddable":true,"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/team-member-id?post=14470"},{"taxonomy":"news-category","embeddable":true,"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/news-category?post=14470"},{"taxonomy":"news-tag","embeddable":true,"href":"https:\/\/innovativemedicines.ca\/fr\/wp-json\/wp\/v2\/news-tag?post=14470"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}